Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry

(2010) Benjamin Terrier et al.   ARTHRITIS AND RHEUMATISM

Rituximab Therapy in Lupus Nephritis: Current Clinical Evidence

(2010) Manuel Ramos-Casals et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

In Situ B Cell-Mediated Immune Responses and Tubulointerstitial Inflammation in Human Lupus Nephritis

(2010) A. Chang et al.   JOURNAL OF IMMUNOLOGY

Updates on the Treatment of Lupus Nephritis

(2010) A. S. Bomback et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Use of rituximab in the treatment of refractory systemic lupus erythematosus: Singapore experience

(2010) A. Lateef et al.   LUPUS

Long-term efficacy and safety of rituximab in refractory and relapsing systemic lupus erythematosus

(2010) F. Catapano et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

(2009) Joan T. Merrill et al.   ARTHRITIS AND RHEUMATISM

Novel B Cell Therapeutic Targets in Transplantation and Immune-Mediated Glomerular Diseases

(2009) F. Vincenti et al.   Clinical Journal of the American Society of Nephrology

Oral Cyclophosphamide for Lupus Glomerulonephritis: An Underused Therapeutic Option

(2009) A. McKinley et al.   Clinical Journal of the American Society of Nephrology

Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

(2009) G. B. Appel et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis

(2009) Jai Radhakrishnan et al.   KIDNEY INTERNATIONAL

Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients

(2009) M. Garcia-Carrasco et al.   LUPUS

Rituximab in systemic lupus erythematosusA systematic review of off-label use in 188 cases

(2009) M Ramos-Casals et al.   LUPUS

An update on the use of mycophenolate mofetil in lupus nephritis and other primary glomerular diseases

(2009) Alice S Appel et al.   Nature Reviews Nephrology

Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids

(2009) R. Pepper et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study

(2009) David Isenberg et al.   RHEUMATOLOGY

Analysis and classification of B-cell infiltrates in lupus and ANCA-associated nephritis

(2008) Oliver M. Steinmetz et al.   KIDNEY INTERNATIONAL

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

(2008) Stephen L. Hauser et al.   NEW ENGLAND JOURNAL OF MEDICINE

B lymphocytes and lupus nephritis: New insights into pathogenesis and targeted therapies

(2007) P. Bhat et al.   KIDNEY INTERNATIONAL